GlobalRPh Renal Dosing Masterv6.6
Evidence addition

Polymyxin B - systemic injection

Local RX List renal extractBase record retrieved 2026-09-09See the evidence for this drug2 sources available - open source summaries, references and comparisons

POLYMYXIN B / Polymyxin B

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (1)

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (2)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

1 additional source qualifications - review before use
Polymyxin B: label-mirror reduction versus professional no-adjustment guidance

The RX mirror calls for renal reduction. UNMC recommends no loading or maintenance reduction for renal impairment or CRRT, citing international consensus. These recommendations are not silently harmonized.

Before applying: Request infectious-disease/pharmacy adjudication, document the chosen source and monitor toxicity. Do not construct a hybrid dose from opposing instructions.

Also check: Polymyxin B: label-mirror reduction versus professional no-adjustment guidance

Rxlist source

GlobalRPh RX List - POLYMYXIN B

Product / population
Polymyxin B - systemic injection; selected renal passages, not a complete prescribing monograph.
Renal measure
Qualitative renal statement; no numerical renal-function threshold inferred.

RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.

Source disagreement: this mirror is not displayed as an uncontested renal dosing standard.

Renal dosing, restrictions and evidence limits

The RX label mirror directs dose reduction in renal damage with nitrogen retention. Its IV paragraph describes a normal-function total of 15,000-25,000 units/kg/day, then directs reduction downward from 15,000 units/kg/day in kidney impairment without a CrCl-specific table. Falling urine output with rising BUN is a reason to discontinue in the warning. This source conflicts with separately attributed UNMC guidance recommending no renal adjustment. Do not construct a compromise dose or confuse polymyxin B with colistimethate. Specialist adjudication is required before selecting a systemic regimen.

Source revision: Source revision date not established in selected retrieval. | Retrieved: 2026-09-09. Retrieval date is not the revision date.

Source: https://globalrph.com/rx-list/polymyxin-b-drug/

Scope: Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 1 source difference / applicability notes

GlobalRPh RX List

GlobalRPh RX List - POLYMYXIN B

Qualitative renal precaution. No complete numerical renal schedule is supplied by this selected finding.

Polymyxin B - systemic injection; selected renal passages, not a complete prescribing monograph.

Renal method: Qualitative renal statement; no numerical renal-function threshold inferred.
Retrieved: 2026-09-09

Read local renal resultOpen original reference
Professional guidance

Polymyxin B - UNMC opposing renal guidance

Professional guidance with defined scope. Publication date, institutional setting and source limitations remain controlling. This is not automatic preference over another source.

Polymyxin B - UNMC opposing renal guidance; selected renal passages, not a complete prescribing monograph.

Renal method: Qualitative renal statement; no numerical renal-function threshold inferred.
Retrieved: 2026-09-09

Read local renal resultOpen original reference

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Product / population check

Confirm the exact formulation before using a renal source

These links compare product identities, not interchangeable doses. A selected summary is not a complete prescribing monograph.

Source-specific review points

Polymyxin B: label-mirror reduction versus professional no-adjustment guidance

Read the attributed comparison notes and source cards below. No conflict has been silently adjudicated.

Source-quality holds
Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources
Jump to renal guidanceRead 1 difference / caution notesClinician guide

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

guideline difference

Polymyxin B: label-mirror reduction versus professional no-adjustment guidance

The RX mirror calls for renal reduction. UNMC recommends no loading or maintenance reduction for renal impairment or CRRT, citing international consensus. These recommendations are not silently harmonized.

How to use this: Request infectious-disease/pharmacy adjudication, document the chosen source and monitor toxicity. Do not construct a hybrid dose from opposing instructions.

GlobalRPh RX List - POLYMYXIN BPolymyxin B - UNMC opposing renal guidance

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Original content / product scopeGlobalRPh RX List - POLYMYXIN BPolymyxin B - UNMC opposing renal guidance
Choose two source checkboxes below.
Exact product and population matter. This added page contains locally stored, source-specific clinical summaries. Historical handbook information, when present, is identified separately and may conflict with U.S. labeling. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Exact product and population

Product identity selected for the separately displayed source protocols below. Reference: https://globalrph.com/rx-list/polymyxin-b-drug/

Exact product and population

Polymyxin B - systemic injection; selected renal passages, not a complete prescribing monograph.

RDM50-SCOPE-polymyxin-b-systemic · Source section: Selected source product scopeRenal section finder
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - POLYMYXIN B

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · Polymyxin B - systemic injection; selected renal passages, not a complete prescribing monograph.

Renal method: Qualitative renal statement; no numerical renal-function threshold inferred.
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-09

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Qualitative renal precaution. No complete numerical renal schedule is supplied by this selected finding.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

The RX label mirror directs dose reduction in renal damage with nitrogen retention. Its IV paragraph describes a normal-function total of 15,000-25,000 units/kg/day, then directs reduction downward from 15,000 units/kg/day in kidney impairment without a CrCl-specific table. Falling urine output with rising BUN is a reason to discontinue in the warning. This source conflicts with separately attributed UNMC guidance recommending no renal adjustment. Do not construct a compromise dose or confuse polymyxin B with colistimethate. Specialist adjudication is required before selecting a systemic regimen.

RDM50-rxlist-polymyxin-b-systemic-d0f99d78e2-C1 · Source locator: Renal/neurotoxicity warning, lines 22-23; intravenous dosing, lines 46-52.

Source-specific limits

Source disagreement: this mirror is not displayed as an uncontested renal dosing standard.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/polymyxin-b-drug/
Retrieved
2026-09-09
Renal-function method
Qualitative renal statement; no numerical renal-function threshold inferred.
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
8ac37f799d45f2e53c6d59f0e99a4393dc53292ca556cd92aab4d70f4a21c419
Separate professional-source layer

University and professional protocols

Professional

Polymyxin B - UNMC opposing renal guidance

Open original reference

Open / share this exact local source

University of Nebraska Medical Center / antimicrobial stewardship · Polymyxin B - UNMC opposing renal guidance; selected renal passages, not a complete prescribing monograph.

Renal method: Qualitative renal statement; no numerical renal-function threshold inferred.
Source date: Page revision not established; page cites 2019 international consensus guidance.
Retrieved: 2026-09-09

Professional guidance with defined scope. Publication date, institutional setting and source limitations remain controlling. This is not automatic preference over another source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

UNMC recommends no polymyxin B dose adjustment for renal impairment or CRRT, applying the CRRT statement to loading and maintenance doses. The page cites the 2019 international consensus guideline. This differs directly from the RX mirror renal-reduction wording. Avoid other nephrotoxins when feasible. This locally attributed institutional guidance is not a product-label instruction or proof of universal applicability; selection of a regimen requires infectious-diseases/pharmacy review. No pediatric, peritoneal-dialysis or colistimethate regimen is inferred here.

RDM50-professional-polymyxin-b-systemic-8e620f96e1-C1 · Source locator: Dose adjustments and concomitant therapy, lines 158-163; dosing table, lines 164-170; reference, line 171.

Source identity and provenance
Source family
professional_guidance
Source
https://www.unmc.edu/intmed/divisions/id/asp/protected-antimicrobials/polymyxin.html
Retrieved
2026-09-09
Renal-function method
Qualitative renal statement; no numerical renal-function threshold inferred.
Source date/version
Page revision not established; page cites 2019 international consensus guidance.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
77cb37001f02ae6a06df14b8d8615e6becf537923dca857770746e9d60dab528

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 1 RX List, 1 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/rx-list/polymyxin-b-drug/
Source retrieval
2026-09-09. This is not the source publication or label revision date.
Original source type
rxlist summary
Local text SHA-256
710632fe8dc2a808be8f4070d0b4aff3d47b879cf7361a65abf530f23fcd8bef
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

This page is an additional exact-product entry, not a recovered GlobalRPh monograph. Its primary scope text and separately attributed clinical summaries are locally included.

Read the full coverage report